Investors Urged to Prioritise Accessible US Healthcare

The article examines the financial and social risks of the U.S. President’s decision to roll back policies that ensured affordable healthcare and medication. The article emphasises that health is often overlooked in investment decisions, besides its critical impact on economies and societies.  

Donald Trump’s executive orders reversed initiatives from his predecessor, including those aimed at making healthcare more affordable for low- and middle-income U.S. citizens and withdrawing the country from the World Health Organization (WHO). Experts warn that restricting healthcare access reduces workforce productivity, ultimately harming businesses and investor portfolios.  

“It’s important to recognise that money will not be made in any sector – whether it’s AI or telecoms or real estate – if peoples’ health is not guaranteed,” the article quotes Jayasree Iyer, CEO of the Access to Medicine Foundation.  

In response to Trump’s recent call for a federal funding freeze, which puts pressure on essential nationwide healthcare services such as the President’s Emergency Plan for AIDS Relief (PEPFAR), Iyer adds, “This is critical in supporting and driving access to HIV medicines and, more recently, preventative care products in over 100 countries around the world.” 

Through this article, investors are being called upon to prioritise accessible healthcare in the US by integrating health into their investment strategies.